Zynex Inc IPO-Jahr
Was ist das IPO-Jahr von Zynex Inc?
IPO-Jahr von Zynex Inc ist 2004
Was ist die Definition von IPO-Jahr?
Börsengang ist ein öffentliches Angebot, bei dem Aktien eines Unternehmens normalerweise an institutionelle Anleger verkauft werden, die ihrerseits erstmals an einer Wertpapierbörse an die breite Öffentlichkeit verkauft werden.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO-Jahr von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Zynex Inc
Was macht Zynex Inc?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Unternehmen mit ipo-jahr ähnlich Zynex Inc
- Agricultural Land Trust hat IPO-Jahr von 2003
- American Equity Investment Life Co hat IPO-Jahr von 2003
- Craven House Capital Plc hat IPO-Jahr von 2003
- Stone Resources Australia hat IPO-Jahr von 2003
- Tri-Star Resources Plc hat IPO-Jahr von 2003
- Zhejiang RuiYuan Intelligent Control Technology hat IPO-Jahr von 2003
- Zynex Inc hat IPO-Jahr von 2004
- CF Industries Inc hat IPO-Jahr von 2005
- Toshiba hat IPO-Jahr von 2005
- Bankfinancial Corp hat IPO-Jahr von 2005
- Blancco Technology Plc hat IPO-Jahr von 2005
- Rich Goldman hat IPO-Jahr von 2005
- Olmix Societe Anonyme hat IPO-Jahr von 2005